Hairy cell leukemia: new understanding of biology and treatment. 1993

A Saven, and L D Piro, and C J Carrera, and D A Carson, and E Beutler
Department of Molecular & Experimental Medicine, Scripps Clinic & Research Foundation, La Jolla, CA 92037.

UI MeSH Term Description Entries
D007372 Interferons Proteins secreted by vertebrate cells in response to a wide variety of inducers. They confer resistance against many different viruses, inhibit proliferation of normal and malignant cells, impede multiplication of intracellular parasites, enhance macrophage and granulocyte phagocytosis, augment natural killer cell activity, and show several other immunomodulatory functions. Interferon
D007943 Leukemia, Hairy Cell A neoplastic disease of the lymphoreticular cells which is considered to be a rare type of chronic leukemia; it is characterized by an insidious onset, splenomegaly, anemia, granulocytopenia, thrombocytopenia, little or no lymphadenopathy, and the presence of "hairy" or "flagellated" cells in the blood and bone marrow. Hairy Cell Leukemia,Leukemic Reticuloendotheliosis,Reticuloendotheliosis, Leukemic,Hairy Cell Leukemias,Leukemias, Hairy Cell,Leukemic Reticuloendothelioses,Reticuloendothelioses, Leukemic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015649 Pentostatin A potent inhibitor of ADENOSINE DEAMINASE. The drug induces APOPTOSIS of LYMPHOCYTES, and is used in the treatment of many lymphoproliferative malignancies, particularly HAIRY CELL LEUKEMIA. It is also synergistic with some other antineoplastic agents and has immunosuppressive activity. 2'-Deoxycoformycin,CI-825,Co-Vidarabine,Deoxycoformycin,Imidazo(4,5-d)(1,3)diazepin-8-ol, 3-(2-deoxy-beta-D-erythro-pentofuranosyl)-3,4,7,8-tetrahydro-, (R)-,NSC-218321,Nipent,2' Deoxycoformycin,CI 825,CI825,NSC 218321,NSC218321
D017338 Cladribine An antineoplastic agent used in the treatment of lymphoproliferative diseases including hairy-cell leukemia. 2-Chloro-2'-deoxyadenosine,2-Chlorodeoxyadenosine,2'-Deoxy-2-chloroadenosine,Leustatin

Related Publications

A Saven, and L D Piro, and C J Carrera, and D A Carson, and E Beutler
July 1986, Seminars in hematology,
A Saven, and L D Piro, and C J Carrera, and D A Carson, and E Beutler
April 2020, Current treatment options in oncology,
A Saven, and L D Piro, and C J Carrera, and D A Carson, and E Beutler
April 2007, Leukemia & lymphoma,
A Saven, and L D Piro, and C J Carrera, and D A Carson, and E Beutler
October 2009, Leukemia & lymphoma,
A Saven, and L D Piro, and C J Carrera, and D A Carson, and E Beutler
January 1993, Postepy higieny i medycyny doswiadczalnej,
A Saven, and L D Piro, and C J Carrera, and D A Carson, and E Beutler
July 2021, International journal of molecular sciences,
A Saven, and L D Piro, and C J Carrera, and D A Carson, and E Beutler
February 2011, Cancer treatment reviews,
A Saven, and L D Piro, and C J Carrera, and D A Carson, and E Beutler
June 2014, Current treatment options in oncology,
A Saven, and L D Piro, and C J Carrera, and D A Carson, and E Beutler
August 2006, Cancer treatment reviews,
A Saven, and L D Piro, and C J Carrera, and D A Carson, and E Beutler
October 2018, JAMA,
Copied contents to your clipboard!